Oxford Ionics and the race towards quantum computers
Dr Chris Ballance, co-founder and CEO of quantum computing spinout Oxford Ionics talks about the commercial challenges, successful funding rounds, and future collaborations.
Tech transfer partnership between universities creates company to transform care for millions of women
Amber Therapeutics successfully closed Series A funding of $100 million (£80 million) from leading healthcare and technology investors in the US and UK.
Oxford Innovation Society (OIS)
Oxford University Innovation recently hosted two landmark events that brought together global investors, leading industry experts and innovative spinouts, showcasing the vibrant ecosystem of collaboration and cutting-edge technology at Oxford.
Oxford Semantic Technologies – an Oxford University spinout specialising in knowledge graph and reasoning technology – acquired by Samsung Electronics
An Oxford University spinout which supports accurate AI applications using Knowledge & Reasoning has been bought by Samsung Electronics.
Enhancing clinical trials: The vital role of Clinical Outcome Assessments
Discover why Clinical Outcome Assessments (COAs) are vital in clinical trials for measuring patient outcomes and ensuring reliable data for regulatory approval and improved patient care.
Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies from University of Oxford research
Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the MRC Weatherall Institute of Molecular Medicine at University of Oxford.
Introducing the recipients of the 2024 Jamie Ferguson Innovation Awards
The third year of the Jamie Awards featured ideas such as cleaner hydrogen use in chemical production, an agrochemical for improving crop resilience to floods, advancements in materials for safer and more efficient batteries, and the development of new medical treatments using 3D printing.
Oxford University Innovation to host leading global investors and spinouts at Deep Tech Investor Day
Oxford University Innovation (OUI) will welcome more than 50 investors today for the first ever Deep Tech focused showcase day in Oxford to connect them with spinout companies seeking investment and partnership.
University spinout OrganOx opens state-of-the-art research HQ in Oxford
OrganOx Ltd, a leading medical technology company specialising in organ preservation prior to transplantation and the treatment of acute organ failure, has opened its new 18,000 square-foot global headquarters for research, development, and production in Oxford.
© Oxford University Innovation